1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Small Business Technology Transfer (STTR) Program" is currently closed and not accepting applications.
Small Business Technology Transfer (STTR) Program is sponsored by National Center for Advancing Translational Sciences (NCATS), NIH. This program promotes collaboration between small businesses and research institutions to commercialize innovative technologies.
It helps small businesses develop and commercialize new translational technologies, with research priorities identified in areas such as preclinical drug discovery and development, biomedical informatics, clinical research, and rare diseases. This program is one of the largest sources of funding for early-stage companies in the United States.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Programs | National Center for Advancing Translational Sciences U.S. Department of Health & Human Services National Institutes of Health Our Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small businesses develop and commercialize new translational technologies.
Small Business Research Priorities We have identified research priorities in the translational space that we would like small businesses to address through the omnibus solicitation. Topics are reviewed biannually to ensure new and cutting edge ideas are considered. If you would like to contact us, send an email to: NCATS SBIR/STTR Program .
Preclinical Drug Discovery and Development Biomedical, Clinical and Health Research Informatics Clinical, Dissemination and Implementation Research Rare Disease and Unmet Needs Learn About Our Research Priorities More SBIR/STTR Information SBIR and STTR Program Benefits The SBIR and STTR programs are one of the largest sources of funding for early-stage companies in the United States.
SBIR and STTR Program Differences The SBIR and STTR programs help entrepreneurial researchers launch small businesses, engage in research and development, and commercialize new products that will benefit the public. See More About the SBIR/STTR Programs Small Business Success Stories Read how our SBIR and STTR programs have helped other small businesses.
Collaborative Drug Discovery Vault: Banking on Shared Data — April 22, 2025 Spectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology — Nov. 19, 2024 Electrifying Invention Can Save Young Lives and Ease Chronic Lung Conditions — Feb.
5, 2024 Artificial Intelligence Is Advancing Clinical Research and Data Quality — April 25, 2023 See More Small Business News We have resources, tips, sample applications and more that may help a small business considering SBIR and STTR funding. Last updated on May 9, 2025
According to the current listing, eligibility includes: Small businesses in the U.S. with fewer than 500 employees, in partnership with a research institution. Confirm the full requirements in the official notice before applying.
The published deadline was May 9, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Small Business Technology Transfer (STTR) Program is funded by National Center for Advancing Translational Sciences (NCATS), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) is sponsored by National Center for Advancing Translational Sciences (NCATS), NIH. This program provides support for institutions to develop and implement mentored research career development programs in clinical and translational science. It aims to nurture the next generation of translational researchers within the CTSA Program network.
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS), NIH. This grant program supports institutional research training grants to create, provide, and disseminate clinical and translational science training and career support programs for individuals seeking a PhD or an equivalent research health professional degree.
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article